Could stem cells help fight frailty? new study begins
NCT ID NCT07462819
First seen Mar 11, 2026 · Last updated May 17, 2026 · Updated 11 times
Summary
This early-stage study tests whether a new cell therapy called Stemis™ is safe for older adults (ages 60–85) with mild to moderate frailty. Frailty causes weakness and slower movement, and no approved drug exists yet. About 12 participants will receive either Stemis™ or a placebo, and researchers will monitor for side effects and measure walking speed, grip strength, and quality of life. The goal is to gather safety data, not to treat frailty directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAILTY SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Taipei Medical University Hospital
Taipei, Taiwan
Conditions
Explore the condition pages connected to this study.